Skip to content

Research and development of early alzheimer's disease screening system based on artificial intelligence technology

Research and development of early alzheimer's disease screening system based on artificial intelligence technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067359
Enrollment
Unknown
Registered
2023-01-05
Start date
2023-01-09
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Interventions

Group 1:
Group 2:
Group 3:

Sponsors

Jincheng General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. AD inclusion criteria: meet the criteria of Alzheimer's disease dementia in ICD-10. Hachinski ischemia index scale (Hachinskiischemical scale, HIS) 0.5 2. MCI inclusion criteria: CDR=0.5 points; Geriatric Depression Scale score 25 points, MMSE > 27 points, CDR = 0 point; 4. Inclusion criteria for normal controls: All subjects need to undergo a complete nervous system examination by a professional neurologist and have no positive signs of the nervous system; the ability of daily living remains normal; there is no chief complaint of cognitive impairment, and the total score of MMSE is > 27 points.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for AD patients: those with a history of cerebrovascular disease and focal symptoms and signs of the nervous system; other diseases that can explain the memory dysfunction and related symptoms of the patient; other physical diseases that can cause cognitive impairment; Mental disorders and developmental disorders of the central nervous system; suffering from diseases or serious physical diseases that cannot cooperate with the completion of cognitive examinations; 2. MCI exclusion criteria: those with a history of cerebrovascular disease and focal symptoms and signs of the nervous system; other diseases that can explain the patient's memory dysfunction and related symptoms; other systemic diseases that can cause cognitive impairment; severe mental illness and developmental disorders of the central nervous system; suffering from diseases that cannot cooperate with the completion of cognitive examinations; 3. SCD exclusion criteria: exclusion of mental or nervous system diseases, long-term use of drugs that cause cognitive decline (Molinuevo et al., 2017); presence of other systemic diseases that can cause cognitive impairment; presence of severe mental illness and developmental disorders of the central nervous system Illness; suffering from an illness that prevents you from cooperating with the cognitive examination.

Design outcomes

Primary

MeasureTime frame
Cognitive assessment;

Secondary

MeasureTime frame
Scale evaluation;Head MRI;Fecal collection;

Countries

China

Contacts

Public ContactYanbin Jin

Jincheng General Hospital

jmzyyjyb@126.com+86 139 3569 0926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026